Bevacizumab 0.500MG Intravitreal There Isn't Lower Than 0.625MG in the Treatment of ROP Type 1
Clinical trial NCT02090322 · UNKNOWN
Trial details
- NCT number
- NCT02090322
- Sponsor
- Universidad Autonoma de San Luis Potosí
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2014-03-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.